These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 15160401)

  • 21. Heterogeneity testing in meta-analysis of genome searches.
    Zintzaras E; Ioannidis JP
    Genet Epidemiol; 2005 Feb; 28(2):123-37. PubMed ID: 15593093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypothesis tests for population heterogeneity in meta-analysis.
    Viechtbauer W
    Br J Math Stat Psychol; 2007 May; 60(Pt 1):29-60. PubMed ID: 17535578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis of repeated measures study designs.
    Peters JL; Mengersen KL
    J Eval Clin Pract; 2008 Oct; 14(5):941-50. PubMed ID: 19018929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints.
    Harbord RM; Egger M; Sterne JA
    Stat Med; 2006 Oct; 25(20):3443-57. PubMed ID: 16345038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testing overall and moderator effects in random effects meta-regression.
    Huizenga HM; Visser I; Dolan CV
    Br J Math Stat Psychol; 2011 Feb; 64(Pt 1):1-19. PubMed ID: 21506942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How should meta-regression analyses be undertaken and interpreted?
    Thompson SG; Higgins JP
    Stat Med; 2002 Jun; 21(11):1559-73. PubMed ID: 12111920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Application of Meta-regression and subgroup analyses of heterogeneity disposal in Meta-analysis].
    Shi XQ; Wang ZZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 May; 29(5):497-501. PubMed ID: 18956686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes.
    Smith CT; Williamson PR; Marson AG
    J Eval Clin Pract; 2005 Oct; 11(5):468-78. PubMed ID: 16164588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey.
    Ioannidis JP; Trikalinos TA
    CMAJ; 2007 Apr; 176(8):1091-6. PubMed ID: 17420491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis in occupational epidemiology: a review of practice.
    McElvenny DM; Armstrong BG; Järup L; Higgins JP
    Occup Med (Lond); 2004 Aug; 54(5):336-44. PubMed ID: 15289591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors.
    Schmid CH; Stark PC; Berlin JA; Landais P; Lau J
    J Clin Epidemiol; 2004 Jul; 57(7):683-97. PubMed ID: 15358396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The power of the standard test for the presence of heterogeneity in meta-analysis.
    Jackson D
    Stat Med; 2006 Aug; 25(15):2688-99. PubMed ID: 16374903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interpretation of tests of heterogeneity and bias in meta-analysis.
    Ioannidis JP
    J Eval Clin Pract; 2008 Oct; 14(5):951-7. PubMed ID: 19018930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis for ranked discovery datasets: theoretical framework and empirical demonstration for microarrays.
    Zintzaras E; Ioannidis JP
    Comput Biol Chem; 2008 Feb; 32(1):38-46. PubMed ID: 17988949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005.
    Mangiapane S; Blettner M; Schlattmann P
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):115-24. PubMed ID: 17955496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Confidence intervals for the overall effect size in random-effects meta-analysis.
    Sánchez-Meca J; Marín-Martínez F
    Psychol Methods; 2008 Mar; 13(1):31-48. PubMed ID: 18331152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An exploratory test for an excess of significant findings.
    Ioannidis JP; Trikalinos TA
    Clin Trials; 2007; 4(3):245-53. PubMed ID: 17715249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring heterogeneity in meta-analyses: needs, resources and challenges.
    Xu H; Platt RW; Luo ZC; Wei S; Fraser WD
    Paediatr Perinat Epidemiol; 2008 Jan; 22 Suppl 1():18-28. PubMed ID: 18237348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidimensional local false discovery rate for microarray studies.
    Ploner A; Calza S; Gusnanto A; Pawitan Y
    Bioinformatics; 2006 Mar; 22(5):556-65. PubMed ID: 16368770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses.
    Brok J; Thorlund K; Wetterslev J; Gluud C
    Int J Epidemiol; 2009 Feb; 38(1):287-98. PubMed ID: 18824466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.